Navigation Links
Misys Wins Prestigious Gold Labels From SWIFT for Entire Trade Services Solutions Portfolio
Date:6/2/2008

LONDON, June 2 /PRNewswire-FirstCall/ --

- Misys Trade Services, Including Front- and Back-Office Solutions, Wins Gold Status

Misys plc (FTSE: MSY.L), the global application software and services company, today announces that it has been awarded the double accolade of winning two SWIFTReady Gold labels for its front-office and back-office trade finance solutions.

Having been the first trade services solutions provider to win the SWIFTReady Trade Services Utility (TSU) label when the category was started in 2007, Misys has again been awarded the 2008 Gold status for its TSU capabilities, available either within Misys Trade Portal or as a standalone solution. Additionally, Misys Trade Innovation has achieved Gold in the SWIFTReady Trade Finance category, underlining its adherence to the SWIFT Standards, its openness, breadth and depth of functionality and flexibility to meet market demands.

Olivier Berthier, Head of Product Management, Misys Trade Services, comments, "We are delighted that we have gained such important stamps of approval from SWIFT for our fully integrated financial supply chain solutions. We have continually adapted our solutions to keep ahead of our customers' and the market's demands and are now able to provide solutions seamlessly linking the front office to the back-office trade finance processing."

Misys Trade Services provides more than 190 customers with solutions for all their trade finance needs, making it the world's best-selling trade finance system provider. Customers of Misys benefit from an integrated portfolio of trade finance, guarantee and factoring solutions which anticipate constantly changing market requirements. Banks are able to improve trade finance volumes by enhancing customer service and broaden revenue opportunities. The offering enables them to process financial supply chain business both efficiently and cost-effectively, thereby providing the edge banks need to stay ahead of the c
'/>"/>

SOURCE Misys plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. United Commercial Bank Extends its Use of Misys Equation and Trade Innovation Systems to Support its Expansion in Taiwan
2. Mybank Goes Live With Misys Equation to Support Rapid Growth and Meet Future Regulatory Requirements
3. Commerzbank Goes Live With Misys Risk Vision 5.4, Following a Successful, On Schedule Implementation Project
4. Misys Facilitates Masraf Al Rayans Expansion of Islamic Banking Operations
5. Childrens Hospital of Pittsburgh psychiatrist receives prestigious NIH award
6. Mobility-enhancing device developed at University of Alberta will receive prestigious da Vinci Award
7. AAHFN President Elect Sue Wingate Received Prestigious 2007 Clinical Excellence in Nursing Award from the Heart Failure Society of America
8. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
9. Amedicas Silicon Nitride Ceramic Bearing Technology Receives Prestigious HAP Paul Award for Use in Total Hip Arthroplasty
10. PARIs Hydrate Wins Prestigious R&D 100 Award
11. Prestigious London Hospital Enters Long-Term Agreement with Varian Medical Systems
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5FDA Launches Orphan Drug Workshop at KGI 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Companion Life Adds Dental Tourism Option to Help Policyholders Save 60761 1Companion Life Adds Dental Tourism Option to Help Policyholders Save 60761 2Companion Life Adds Dental Tourism Option to Help Policyholders Save 60761 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 1SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 14SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 14733 1SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 14733 2